Documents

In this section, you will find reviews and digests regarding the status of antiviral research and development on various diseases of interest, along with other types of reports and listings.


To buy a document, click on the corresponding button (following the description). You will be transferred to a secure online PayPal® transaction site for payment through your PayPal® account or credit card. Upon payment, you will receive an email that will provide you with a link to download your document. (Payments by cheques also accepted)

Please note that this link is time-sensitive and will expire after 24 h!

 

Documents available below:

1. Companies in Antivirals 2019
2. Viral Vaccines Based on Viral Expression Vectors 2019
3. RSV R&D status 2019
4. Zika virus R&D status 2019
5. Chikungunya virus R&D status 2019
6. Dengue virus R&D status 2019
7. MERS and SARS viruses R&D status 2019
8. Ebola and Filoviruses R&D status 2019
9. Norovirus R&D status 2019
10. Published Lead Compounds with Antiviral Activity

 

1. Companies in Antivirals 2019

- Last update Oct. 2019
- More than 365 companies listed, worldwide distribution
- Running active programs in antiviral drugs and vaccines discovery and development
- Company name, website, physical address, email address, phone/fax numbers, contact names, and virus programs
- Provided as an Excel spreadsheet

- Price: $295 US

 

2. Viral Vaccines Based on Viral Expression Vectors 2019

- 277 vaccines listed
- Global coverage
- Sponsors/Co-sponsors, Name of vaccine with synonyms, Type of vaccine, Viral vector used, Virus target, Development status
- Includes vaccines at all stages of development
- All types of viral expression systems (MVA, Adeno, AAV, etc.)
- Provides insights into novel approaches and targets
- Future directions and perspectives

- Excel format

- Last update Sep. 2019

- Price: $325 US

 

3. RSV R&D status 2019

- Last update Oct. 2019
- 149 products listed, all stages of development
- Over 100 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$235 US

 

4. Zika virus R&D status 2019

- Last update May. 2019
- 68 products listed, all stages of development
- More than 60 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$100 US

 

5. Chikungunya virus R&D status 2019

- Last update May. 2019
- 29 products listed, all stages of development
- More than 26 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel spreadsheet

- Price:
$100 US

 

6. Dengue virus R&D status 2019

- Last update Sep. 2019
- 109 products listed, all stages of development
- Over 80 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$125 US

 

7. MERS and SARS viruses R&D status 2019

- Last update Aug. 2019
- 72 products listed, all stages of development
- More than 65 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel spreadsheet

- Price:
$100 US

 

8. Ebola and Filoviruses R&D status 2019

- Last update May. 2019
- 120 products listed, all stages of development
- More than 72 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel document

- Price:
$230 US

 

9. Norovirus R&D status 2019

- Last update May. 2019
- 16 products listed, all stages of development
- More than 18 organizations listed, worldwide distribution
- Sponsor, Product, Type of product, Mode of action (or Type of vaccine), Development status, Notes on status
- Provide
d as an Excel spreadsheet

- Price:
$100 US

 

10. Published Lead Compounds with Antiviral Activity

- Over 350 lead compounds included, developed against 15 families of Virus and 32 individual viruses
- Excel format with information selected to provide a quick overview of compound's key attributes
- Organizations (originators) and compound’s designation, plus References
- Mechanisms of action when deciphered (including several new targets)

- Activity on viral target and/or virus replication in cell-based assays (IC50, EC50)
, along with Cytotoxicity

- Classified by target Virus types/Families

- Chemical structures (including several novel drug scaffolds)

- Price:
$295 US